Skip to main content

Table 1 Baseline characteristics of the participants

From: Multi-trajectories of lipid indices with incident cardiovascular disease, heart failure, and all-cause mortality: 23 years follow-up of two US cohort studies

Characteristics Trajectory sample (n = 14,373) Prospective sample (n = 12,129)
Age, y 56.3 ± 8.1 63.3 ± 7.3
Sex
 Women, n (%) 7839 (54.5) 6750 (55.7)
 Men, n (%) 6534 (45.5) 5379 (44.4)
Race
 White/Caucasian 9593 (66.7) 8140 (67.1)
 African American/Black 3138 (22.0) 2605 (21.5)
 Hispanic/Latino 1044 (7.3) 889 (7.3)
 Asian/Chinese 571 (4.0) 495 (4.1)
Body mass index, kg/m2 27.6 (5.2) 28.4 (5.5)
Total cholesterol, mg/dL 206.7 (39.4) 197.3 (36.7)
LDL cholesterol, mg/dL 129.9 (36.8) 119.3 (33.1)
HDL cholesterol, mg/dL 52.2 (16.2) 51.7 (16.3)
Triglycerides, mg/dL 122.7 (63.6) 132.8 (77.4)
Systolic blood pressure, mmHg 120.9 (18.5) 125.1 (19.0)
Diastolic blood pressure, mmHg 72.5 (10.4) 70.6 (9.9)
Hypertension 4585 (32.0) 5271 (43.5)
Antihypertensive drug 3810 (26.5) 4586 (37.8)
Lipid-lowering drug use 2609 (18.2) 3799 (31.3)
Diabetes mellitus 1269 (8.8) 1730 (14.3)
Current smoking 2634 (18.4) 1569 (12.9)
Current drinking 8510 (59.5) 6114 (50.4)
  1. Numbers represent mean (standard deviation) for continuous and frequency (%) for categorical variables
  2. Characteristics for the trajectory sample were measured at the baseline (the first examination cycle)
  3. Characteristics for the prospective sample were measured at the fourth examination cycle
  4. HDL high-density lipoprotein, LDL low-density lipoprotein